Views & Analysis Budget impact and cost effectiveness: Can the UK learn from ... Leela Barham examines the approach of the Institute for Clinical and Economic Review.
Views & Analysis The budget impact of new medicines What could be the impact of proposed new ‘budget impact threshold’ for drugs?
Views & Analysis UK Pharmaceutical Leaders Survey 2017: Brace for Turbulence A look ahead to the UK market in 2017 through the eyes of pharma industry leaders
News Chatbot will help deal with calls to NHS 111 Six-month trial will test Babylon Health across north central London.
Views & Analysis The biggest NHS deficit: not money but data Information gleaned from data is the key to making health services safer, more efficient and cost effective.
Views & Analysis Fast-track appraisals and Managed Access Agreements Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
